The agents display physicochemical properties that favor extraction of iron beyond membrane barriers of Plasmodium falciparum-infected red blood cells. W e studied the in vitro antimalarial potency of RSFs and their relationship to the membrane permeation properties of these agents. The mode of RSF action involves: (1 ) fast access to intracellular compartments of parasitized cells; (2) selective and high-NTRAERYTHROCYTE growth and development of hu-I man malaria parasites is highly dependent on iron (111) to the extent that it is arrested in the presence of iron (111) chelators.'-4 Previous studies suggested that the iron sources affected by desfemoxamine (DF0)1-6 and related hydroxamates7 reside inside the parasite and not at the level of host red blood cell (RBC)1,3,7 or serum source^.*^^ Possible mechanisms involved in the antimalarial action of these iron chelators are sequestration of iron (111) from vital sources, such as storage proteins, low molecular weight siderophores, iron centers of key parasite enzymes, such as ribonucleotide reductase,"." or the scavenging of iron from degraded hemoglobin." Previously, however, identification of these putative targets had not been accomplished.
W e have designed two subfamilies of lipophilic iron (111) chelators previously termed reversed siderophores (RSFs).
The agents display physicochemical properties that favor extraction of iron beyond membrane barriers of Plasmodium falciparum-infected red blood cells. W e studied the in vitro antimalarial potency of RSFs and their relationship to the membrane permeation properties of these agents. The mode of RSF action involves: (1 ) fast access to intracellular compartments of parasitized cells; (2) selective and high-NTRAERYTHROCYTE growth and development of hu-I man malaria parasites is highly dependent on iron (111) to the extent that it is arrested in the presence of iron (111) chelators.'-4 Previous studies suggested that the iron sources affected by desfemoxamine (DF0)1-6 and related hydroxamates7 reside inside the parasite and not at the level of host red blood cell (RBC)1,3,7 or serum source^.*^^ Possible mechanisms involved in the antimalarial action of these iron chelators are sequestration of iron (111) from vital sources, such as storage proteins, low molecular weight siderophores, iron centers of key parasite enzymes, such as ribonucleotide reductase,"." or the scavenging of iron from degraded hemoglobin." Previously, however, identification of these putative targets had not been accomplished.
DFO is an iron chelator with remarkable therapeutic performance,13 including antimalarial activity both in ' and in v~v o .~-~ However, because of its relatively slow and apparently selective permeation into the advanced growth stages of Plasmodium falciparum-infected cells,'3.14 its biological activity is slow to develop, ie, it demands relatively long exposures of cells at mature stages of parasite growth.'.' I We have undertaken the design and synthesis of lipophilic iron (111) carriers, which show requisite metal ion specificity and binding affinity but display fast penetration across membrane bamers so that they can gain rapid access into parasite compartments of essential iron need. In a previous study7 we introduced the major prototype of a novel family of antimalarial agents that we termed reversed siderophore (RSF), that is, siderophores with relatively high lipophilic properties that subserve their permeation into cells. By virtue of their hydrophobic side chain and high iron (111)-binding efficiency, selected members of that subfamily showed various advantages over DFO as antimalarial. These included IO-fold lower concentrations of inhibitor which reduce growth by 50% (IC5' values), similar effects on all erythrocytic stages of parasite growth, and considerably faster rates of action.' Because iron (111) binding to RSFs completely abolished their antimalarial effect, it was implied that the arrest of parasite growth involved sequestration of critical iron and not the formation of intracellular toxic iron (111)-ligand complexes, as proposed for other classes of iron (111) chelators."
To explore the mode of action of RSFs as antimalarials, we studied the molecular properties that confer antimalarial activity to RSFs. The molecular design of these agents is predicated on biomimetic and modular approaches described earlier,' which allowed systematic substitutions of a prototypic backbone with groups of different defined chemical character. The antimalarial activity of two families of RSFs were studied in in vitro cultures of P falciparum in terms of: (1) ICso values and speed of drug action, ( 2 ) developmental stage of drug sensitivity, (3) irreversibility of action on the overall biosynthetic capacity of the parasite and (4) drug permeation into infected and uninfected cells. The studies indicate that permeation plays a dominant role in the antimalarial activity of iron chelators and is a major determinant in the irreversible inhibition of parasite growth.
MATERIALS AND METHODS
The synthetic scheme for the preparation ofthe various RSFs and their iron (111) complexes was described previ~usly.~.'~ Synthesis of N-(7-nitrobenz-2-oxa-1,3-diazole)-DFO (NBD-DFO) is given elsewhere.16 Desfemoxamine B (DFO), was obtained from CibaGeigy (Basel, Switzerland). All other chemicals were from Sigma Chemical Co (St Louis, MO) or best available grade. Radiochemicals were from the Radiochemical Centre (Amersham, United Kingdom).
Parasite cultures. The P falciparum strain ITG2Gl (Brazil, cloned; a gift of Dr L.H. Miller, NIH) was used for all experiments and was maintained in culture flasks of human erythrocytes by a modified version17 of Trager and Jensen's method18 as described elsewhere." Parasitemia values were obtained by differential counting of parasite growth stages on Giemsa-stained smears.
The antimalarial activity of RSFs was assayed as described previo~sly.~ The compounds were added from concentrated stock solutions in dimethyl sulfoxide (DMSO) to microcultures (24 wells; Costar, Cambridge, MA) containing infected RBCs (2.5% hematocrit and 2% parasitemia). The cultures at ring stage were synchronized previously by incubation in 300 mmol/L alanine and 10 mmol/L TRIS-C1, pH = 7.4. After the
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Blood, Vol81, No 1 (January 1 DFO and the different RSF derivatives were precomplexed to iron by the addition of concentrated stock solutions of 20 mg/mL carriers to 59FeC1, (Amersham) in 0.5 mL of 150 mmol/L NaCI, 10 mmol/L HEPES at 3 to 5 molar excess of carrier for 1 hour at room temperature. To begin the flux, normal or parasitized RBCs that had been washed three times in saline buffer and resuspended in the same buffer supplemented with 5% bovine serum albumin, 2.5 mmol/L citrate, and 2 mg/mL glucose were added to radioactive 59Fe-complexes at a final suspension of 20% hematocrit. After incubation at 37"C, 75 pL suspension was removed in duplicate aliquots for each time point, placed in plastic 15-mL test tubes (Sarstedt, Niimbrecht, Germany) and centrifuged 1 minute at 2,500g. The supematant was removed and the pellet immediately placed on ice. After all sampling was completed the pellets were washed twice in 15 mL of ice cold buffer containing 50 mmol/L EDTA and lysed in distilled water. Radioactivity (gamma emission, 700 to 1,300 keV) was counted and the cell number for each sample determined from hemoglobin absorption of the lysate at 410 nm.I9
Trophozoite-stage parasites were obtained from step gradient of Percoll (Pharmacia, Uppsala, Sweden)-3% L-alanine in phosphate-buffered saline (10 mmol/L Na-phosphate, 150 mmol/L NaCI, pH 7.4).*' Cell suspensions of 100% parasitemia were adjusted to 1% hematocrit and placed in RPMI growth medium Uptake of radioactive carrier-Fe complexes.
Extraction of chelatable iron.
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supplemented with 50 mmol/L sucrose and 20 mmol/L glucose. Pretreatment of cells was accomplished with 12 pmol/L of the indicated RSF or DMSO for 2 hours at 37°C at which time the cells were washed twice in X500 volumes of buffer containing 150 mmol/L NaCI, 10 mmol/L HEPES, and 50 mmol/L sucrose, pH = 7.4. Next the cells were incubated for an additional 3 hours in 6.8 pmol/L NBD-DFO and washed to remove fluorescent probe. Measurements of chelatable iron were performed in the trichloroacetic acid (TCA)-soluble fraction of freeze-thaw lysates as described previously.'6
RESULTS
Molecular properties of the RSFs family of iron (III) chelators. The RSF design is based on a biomimetic approach and modular assembly that allows formation of iron-binding cavities and systematic substitutions that confer the desired chemical character to the
This design is achieved in the tripod topology, which consists of a carbon anchor from which extend bridges to the three hydroxamate groups that make up the iron (111)-binding cavity (Fig I) . The overall construct enables substitution of amino acids of variable hydrophobicity into the bridges (R group). Re1 Fe spective of the subfamily, the inhibitory potency of the an RSF correlates with the magnitude of its partition coefficient and therefore of its lipophilicity. All the derivatives display iron (111)-binding affinities of the same order of magnitude as DFO, and therefore this parameter would seem a priori to play a secondary role in determining the difference in the antimalarial activity of these series of RSFs. The best correlation between ICs0 values and physicochemical properties was obtained when ICs0 was plotted against the product of relative iron (111)-binding and partition coefficient (Pmff) (Fig  2) . Derivatives of m 1 and m2 fall on the curve according to hydrophobicity of amino acid substitution. In the m2 subfamily a minimum value of 2 to 3 for product of relative iron (111) binding *Pcoeff is required for potent antimalarial activity, IC5o < 5, whereas L-val of m l subfamily shows a product of I , which seems sufficient for high activity, ICs0 = 4 (Fig 1) . The differences in ICs0 values of L and D isomers of ileumz derivatives indicate that the predominant biological effect on parasites is probably not of the level of specificity as those displayed by siderophore receptors of the plant and bacterial ~e l l s .~~~~~
The speed of action and stage sensitivity of RSFs was assessed by measurement of percent parasitemia (Tables 2 and 3 ) and of total parasite nucleic acid synthesis during exposure to various RSFs and DFO (Fig 3) . The RSFs exert their inhibitory effects throughout the parasite asexual cycle as evident by the demonstrable inhibition of growth found at both the trophozoite (Table 3 and Fig 3A) and ring (Table 2 and Fig 3B) ileu or leu substitutions cause marked depression in the rates of nucleic acid synthesis even after short exposure times. The speed of action of RSFs is clearly manifested in the profiles of nucleic acid synthesis that diverge from those of control. The extent of this divergence is apparent in the lower average rates of synthesis for different intervals of drug exposure as compared with control (DMSO) (Fig 3 inset graphs) . At trophozoite stage the rank order for RSF speed of action was ileum2 was greater than leu,, , which was greater than ileu,, , as determined during early exposure periods (Fig 3A inset  graph) , and at ring stage, m 1 and m2 were equally effective at inhibition of initial rates (Fig 3B inset graph) . After 12 to 13 hours of exposure no increase in the level of hypoxanthine incorporation was detected in either rings or trophozoites, indicating complete shutdown of nucleic acid synthesis.
Time dependence for induction of irreversible growth arrest at the trophozoite and ring stages: RSFs versus DFO. In our previous study we showed that RSFl (m2, ileu) arrested parasite growth at both ring and trophozoite stages and that the inhibitory effect prevailed after washing the cells.' To determine if the speed and mode of action (continuous v irreversible) of the various RSFs as compared with DFO were dependent on the molecular properties of RSFs, we tested various amino acid derivatives of both m 1 and m2 subfamilies on parasites at the trophozoite stage. Table 1 .
For Data are given as percent parasitemia at 0 and 24 hours after drug administration to a synchronized culture containing 10% ring forms, and as percent trophozoites and rings present after 24 hours incubation with drug relative to the 10% rings originally present (percent control).
producing irreversible effects on trophozoite growth as the leu member of the m2 subfamily. These results are in contrast to those obtained with RSF-Ileum2 and DFO on rings ( Fig  5) . Rings are considerably more susceptible to RSFs than DFO at either mode of inhibition (continuous or irreversible).
This property is particularly evident after 5 hours exposure to RSF, at which point DFO hardly affected nucleic acid synthesis. The differential susceptibilities of rings and trophozoites manifested either during continuous exposures to RSFs and DFO or by remaining after removal of the drugs (irreversible inhibition) can also serve as an indication that the growth assay based on nucleic acid synthesis provides a reliable measure for assessing stage dependence of drug susceptibility. This is of importance because of the likelihood of minor (undetectable) contaminations (1% to 5%) of seemingly synchronized cultures of rings with metabolically active trophozoites (1 % to 5%). Nonetheless, determination of stagerelated parasitemia of drug-treated cultures by light microscopy (Tables 2 and 3 ) confirmed the results obtained by measuring nucleic acid synthesis: with continuous exposure to drugs for 24 hours, trophozoites were arrested by either DFO or RSFs, whereas rings were susceptible primarily to RSFs. However, irreversible arrest was obtained primarily by DFO action on trophozoites and by RSF-ileum2 action on rings (Tables 2 and 3) .
Permeability of RSFs versus DFO into normal versus infected RBCs and removal of chelatable iron.
In a previous study14 Fritsch and Jung showed that 14C-DF0 was taken up by RBCs and that after 5 hours exposure it reached intracellular levels that were threefold to fourfold higher than those attained in normal RBCs. Assuming the entire RBC space is drug accessible, the estimated levels attained intracellularly correspond to less than 5% of the extracellular concentration of DFO. Because of the fact that RSFs have markedly greater lipophilicity than DFO, we predicted faster penetration of these compounds and therefore greater capacity for chelation of intracellular iron after short exposure times. Penetration of free RSFs into normal and infected RBCs was estimated by monitoring uptake of the R S F S -~~F~ (111) complexes into infected and uninfected cells. To confirm actual uptake of Fe-RSF ileum2 rather than adsorption to the outer membrane, cells were thoroughly washed and lysates were subjected to 80,OOOg centrifugation for 20 minutes. More than 90% of the total counts were found in the cytosol fraction (results not shown). Figure 6 shows rapid penetration of RSF-ileum, iron (111) complexes into both normal and infected RBCs with tl,Z = 2 to 3 minutes. Maximum uptake was attained after 10 to 15 minutes at which point the level of 4 nmol/ 10" cells is approximately equal to the equilibrium concentration of 5 pmol/L external Fe (Fig 6A) . Identical uptake kinetics were obtained with RSF-leuml . Similar profiles were also obtained for efflux of complex preloaded cells (not shown). In contrast, the more hydrophilic RSF 1-alam2, whose relative PcoeK is considerably smaller than those of the leu or ileu congeners (Table l) , was hardly taken up as iron (111) complex by infected cells during the first hour of exposure. Even after 8 hours incubation it attained an intracellular level of less than one tenth the external concentration (Fig 6A) . Figure 6B compares DFO-Fe uptake into normal and infected RBCs over an 8-hour time course. The uptake trend into infected RBCs is approximately twice that of normal RBCs yet the concentration of intracellular Fe-DFO after 8 hours indicates an uptake level that is 20-fold lower than that attained by hydrophobic RSFs after 10 minutes (Fig 6A) . To the extent that the values of uptake obtained in this work for the DFO-iron (111) complexes are comparable to those obtained by others for free I4C-DF0,l4 we assume that permeation of the complexes provides a reliable approximation for free chelator permeation.
The assumption that permeation of iron (111) complexes provides a measure for free ligand permeation is probably applicable to the rapidly penetrating iron (111) were similar and relatively high (above 10-in absolute scale for leu and ileu congeners of m 1 and m2 subfamilies, Table  1 ). On this basis, the results shown in Fig 6A reflect the permeability of the free RSF ligands. Therefore, we might presume that permeation of free ligand into cells should also lead to iron (111) extraction from the cells and its delivery in the medium. We have followed the depletion of chelatable iron from infected RBCs after 2-hour RSF treatment (Table  4 ). The assay of chelatable iron involved fluorescence iron quenchingtacid-EDTA dequenching using the fluorescent probe NBD-DF0.I5,I6 Table 4 shows the results of experiments in which pretreatment of trophozoites with RSF ileum2 reduced the amount of chelatable iron by 5-to 10-fold. The amount of chelatable iron detected in noninfected RBCs was approximately 50-fold lower than in parasitized RBCs and was hardly affected by pretreatment with RSF. If anything, it slightly increased after RSF treatment.
DISCUSSION
Pursuant to our initial study of RSFs as antimalarial agents,' we show that the inhibitory potency of RSFs is dic- We have assumed in this work that the permeation of RSFsiron (111) complexes across the membranes of parasitized cells provides a measure for permeation of the free chelators. This assumption holds for the most hydrophobic RSFs, which display high and comparable values of partition coefficient (octanol/water) for either the free or the complexed forms. Even for the hydrophilic DFO, it is remarkable that uptake of iron (111)-DFO into infected cells (Fig 6B) is qualitatively and quantitatively similar to that obtained with free DF0.14 In contrast to DFO, the highly lipophilic RSFs attain rapid chemical equilibrium ( volume, which includes the parasite. This result alone could be sufficient to explain the vast difference in ICso values of the various RSFs and DFO and also their markedly different speed of action. Assuming similar iron extraction capacities, which is the case for various RSFs and DFO, faster access to iron pools might lead to faster biological effects, as previously i n d i~a t e d .~' ?~~
The subfamilies of RSFs differ in the structure of the hydroxamate-binding cavity and their molecular dimension25 (Fig 1) . Although the relative contribution of both physicochemical parameters to the antimalarial potency of RSFs might vary for the different structural congeners (Table l) , their combined properties correlate reasonably well with their antimalarial potency (Fig 2) .
The results of this study supplement our recent findings that show strict dependence of DFO and methylanthramilic-DFO antimalarial activity on direct access of hydrophilic drugs to the parasite via an aqueous access route,26 recently identified as a parasitophorous This pathway of access for drug entry into parasites by no means circumvents the (from methanolic stock solutions). The radioactive complexes were then added to 20% hematocrit cell suspensions and flux was measured as described in Materials and Methods. Specific activity was 485,000 cpm/nmol and 369,000 cpm/nmol for the RSF and DFO uptake experiments, respectively. Cell number was determined from hemoglobin absorption of lysate at 41 0 nm.Ig need for drug to diffuse across the parasite membrane, probably the rate-limiting step in the overall uptake process. Lipophilic RSFs can reach the parasite either directly from the medium or after permeating into the host cell, whereas more hydrophilic RSFs (eg, RSF-ala), in analogy with DFO and Iron extractions were performed on cell suspensions treated (+) or untreated (none) with 12 Mmol/L RSF-l l eu,, for 2 hours at 37"C./ Fluorescence assays of chelatable iron in noninfected (NRC) and in parasitized (IRC) RBCs are described in Materials and Methods.
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The enhanced membrane permeation properties of lipophilic RSFs shed light on the mode of antimalarial action of hydroxamate iron chelators. Previous studies*,' ' claim stagedependence of DFO for the mature trophozoite/schizont and thereby imply that the critical pool or target of chelatable iron of the parasite is available at a specific time during its intraerythrocytic development. These studies2>'' did not fully consider the slow penetration of DFO across RBC membrane in general and the limited access of this hydrophilic drug to the parasite. Therefore, the apparently poor inhibitory effect of DFO on rings might merely reflect its poor accessibility to the parasite at early stages of growth. In this study we have clearly shown sensitivity of both ring and trophozoite stages to RSFs. On this basis, the induction of growth arrest by hydroxamate iron chelators seems to result from access to resident iron pools and sequestration of essential iron that is maintained for the survival of the parasite at various stages of metabolic activity or development.
The possible use of RSFs as antimalarials depends also on their capacity to exert irreversible damage to parasites. This capacity depends not only on drug properties per se, but also on the potential of the parasite for replenishing iron pools after drug removal. Faster permeating and therefore faster acting drugs, such as some lipophilic RSFs, might act on parasites at relatively faster rates but also in a reversible mode because, on drug removal, metabolically active forms, such as trophozoites, seemingly overcome the growth arrest by mobilizing metabolic iron. However, the fast permeating RSFs have an advantage in that they demonstrably permeate into rings and irreversibly affect their development. On the other hand, slower permeating drugs, such as DFO, exert minor effects on rings but act on trophozoites, although at higher concentrations and with slower rates than RSFs. However, most of the inhibitory effect of DFO on trophozoites is probably caused by its retention in the parasite after external drug removal (Fig 4) . This information regarding stage dependence and speed of action of antimalarial drugs has implications for identification of the putative iron-containing targets that are affected by the chelators and their relationship to the mode of antimalarial action. In a subsequent study we further explore RSF mode of action on ring and trophozoite stages and the strong implication that ribonucleotide reductase iron centers are key but not sole targets for RSFs and DFO inhibition of parasite growth.28
In presentation of the significant differences in potency and speed of action of various RSF derivatives we do not rule out the possibility that also the unique structural features of these compounds confer a capacity for chelation and removal of iron from target enzymes, iron carriers (siderophores), and storage sites that are either poorly accessible or not recognized by DFO and hydrophilic iron chelators. For D and L isomers of RSF-ileum2, it is not clear at this stage to what extent the difference in their antimalarial potency might be contributed by a specific (ie, receptor-like) interaction of the chelator with a component of the parasite (eg, a putative siderophore receptor). Such interactions have been amply described in the microbial and plant ~o r l d~' .~~,~~ as part of the mechanisms of iron (111) acquisition from extracellular sources.29 For the m 1 and m2 congeners of RSF-ileu, the difference in their speed of action might stem from conformational differences of their iron (111) complexes (Fig I) . Further structure-activity relationship studies and chemical analysis of drug fate within cells should provide further information on those questions. Several iron-binding compounds presented in this study were also tested on various mammalian cell lines in culture and were shown to cause no short-term toxic effects.' Although RSF-ileum2 also has demonstrable in vivo antimalarial activity with no apparent adverse reactions,30 the information presently available is insufficient for assessing its therapeutic potential and toxicity.
